Keck School of Medicine of USC
@keck
🏥 The official account of the Keck School of Medicine of USC. 🩺 Igniting discovery in research, education, health and health equity. 👩🔬 Follow us for #MedicalResearch #MedSky #Science #Health and learn more at keck.usc.edu
New in Women's Health Issues: Keck School of Medicine of USC researchers led an expert panel synthesizing 100+ studies on intimate partner violence among veterans, recommending broader VA screening and a "no wrong door" clinical approach. https://bit.ly/4fhucUe
New in Communications Medicine: Keck School of Medicine of USC researchers tested Lumipulse G p-tau217 and PrecivityAD2 blood assays in 39 adults with Down syndrome, finding accuracy nearly matching general population results for detecting amyloid pathology #alzheimersresearch https://bit.ly/4wleb5C
New NIH grant funds Keck School of Medicine of USC and Rancho Los Amigos research mapping how stroke disrupts brain to bladder connectivity via fMRI and diffusion MRI, testing whether imaging biomarkers can predict response to spinal cord stimulation. https://bit.ly/4vXIa2H Photo/Stevens INI
USC in the house at Comic-Con✌️ @summerin3d.bsky.social, PhD, and @virtuallyjon.bsky.social, PhD, from USC's 3D lab, the Center for Innovation in Medical Visualization (CIMV), hit the stage at Comic-Con Friday July 24 at 10am. Get your #FightOn sign ready when they're introduced! #SDCC #SDCC2026
New in Genome Biology: USC researchers used Region Capture Micro-C and CRISPR to show prostate cancer enhancers form hierarchical 3D networks, not isolated switches. Deleting "central hub" enhancers silenced cancer genes and slowed tumor growth. #CancerResearch https://bit.ly/4fdBdFC
MS affects every patient differently, but a new study of 42,000+ U.S. deaths is revealing patterns linked to age, race and geography. High blood pressure and cardiac arrest also linked to rising mortality. #MultipleSclerosis https://bit.ly/4vEXReV
New in @natcomms.nature.com: Keck School of Medicine of USC researchers identify thymulin, a thymus-derived hormone, as a driver of age-related inflammation. Restoring it in older mice improved cancer survival and anti-PD-1/PD-L1 response. #CancerResearch https://bit.ly/3Tbywfi
Dean's POV 📸 White Coat ceremony X 4 Every August, a new class puts on that white coat for the first time. I've stood at enough of these now to know the moment never gets old. This year's ceremony is August 7, and I'm already looking forward to it. #HealOn ✌️
PET Scan, CT, & MRI: What each one tells your doctor Break it down with Dr. Kim, resident physician in molecular imaging and therapy.
New in Gastroenterology: Keck School of Medicine of USC researchers identify a DR5/Lig3 feedback loop that helps explain why MSI and dMMR colorectal cancers respond better to immune checkpoint inhibitors. Human tumor data backs up the mouse model findings. #CancerResearch https://bit.ly/4wJ2N3t
An FDA commissioned review from the Keck School of Medicine of USC finds ADHD stimulant misuse among U.S. adults under 30 fell from 7.5% (2016) to 3.7% (2023) across 64 studies. Frequent misuse in a smaller subgroup stays an open question. #ADHD https://bit.ly/4h4en4v
Hearing studies use pure tones, but real ears handle speech and music that shift constantly in pitch and volume. Karolina Charaziak, PhD (Keck School of Medicine of USC) won a $3.3M NIH R01 to study how the cochlea processes sound. #Audiology https://bit.ly/4p6yC3H
Dean's POV 📸 It was wonderful to share thoughts and USC experiences with a group of faculty at our sign-up faculty lunch last week. Conversations like these are part of why I love this job, grateful for the time and honesty everyone brought to the table.
New in @science.org : USC researchers mapped an unrecognized developmental axis in the human kidney, then engineered synthetic organizer cells to guide kidney organoid formation more faithfully. stemcell.keck.usc.edu/synthetic-or... #RegenerativeMedicine
Dean's POV 📸 Taken from my office window when the Lineage fire broke out in Boyle Heights. Our fac/staff/students distributed thousands of masks/air purifiers, activated community health workers & generated real-time data on air quality to protect the most vulnerable.
Too many people in underserved communities still face barriers to timely breast cancer care. @USC.edu and @novartis.bsky.social are working together to improve #BreastCancer screening, access, and outcomes in underserved communities. https://bit.ly/4eYRBJR
Dean’s POV 📸 Celebrating our incredible faculty 🎉 Gregory Harlan, M.D., M.P.H. – Leonard Tow Humanism in Medicine Award Enrique L. Ostrzega, M.D. – Kaiser Permanente Excellence in Teaching Award, Clinical Science Kevin A. Nash, Ph.D. – Kaiser Permanente Excellence in Teaching Award, Basic Science
New in Alzheimer's & Dementia: a Stevens INI team at the Keck School of Medicine of USC analyzed amyloid PET data from 17,000+ adults via GAAIN. APOE ε4 predicted amyloid pathology more weakly in Hispanic participants. A case for diverse cohorts. https://bit.ly/4ehYyWk #AlzheimersResearch
USC's first psychedelic trial pairs psilocybin with mindfulness meditation, asking whether contemplative training deepens the therapy's effects. It enrolls 72 adults and tracks EEG, fMRI, and biological markers before and after treatment. #Neuroscience https://bit.ly/4a7oWQa
Dean's POV 📸 Pride Month is a time to celebrate who we are and affirm who we welcome. To our LGBTQ+ students, faculty, staff, and patients: you are seen, valued, and celebrated here. 🏳️🌈 (USC Photo/Richard Carrasco III)
Nearly all people with Down syndrome develop Alzheimer's brain changes by age 40. A $3.3M gift to USC is funding five new clinical trial sites and a first-of-its-kind program hiring Research Ambassadors with Down syndrome to change that. https://bit.ly/4uwjJJ0
Bipolar disorder isn't about one broken brain region, it's about wiring. USC Stevens INI mapped 959 brains/16 sites and found less efficient networks in circuits tied to emotion & reward.https://keck.usc.edu/news/usc-study-maps-brain-network-changes-linked-to-bipolar-disorder-severity-and-treatment/
Dean's POV 📸 What's inside a vape matters more than how often you use it. Our USC Department of Population and Public Health researchers found flavor and device type account for 66.6% of gene expression changes across 3,124 observations, with direct implications for FDA regulation. #PublicHealth
Singer/songwriter Stevie Nicks—first woman inducted twice into the Rock and Roll Hall of Fame—has completed a $3M endowed chair to honor Joseph Sugerman, MD, her longtime ear, nose and throat specialist. https://keck.usc.edu/news/stevie-nicks-deepens-her-usc-legacy-with-major-gift/Singer/songwriter
Scientists at the Keck School of Medicine of USC built a brain "growth chart" from 54,583 MRI scans. It detected Alzheimer's and schizophrenia-linked changes before symptoms. https://keck.usc.edu/news/new-reference-map-of-the-brain-may-transform-how-scientists-detect-disease/
Your vape flavor changes your genes more than how often you vape. USC researchers found 66.6% of vaping-related gene changes across 3,124 genes are driven by flavor and device type. Published in Frontiers in Oncology. https://bit.ly/43cmALU
Dean's POV 📸 Medical and engineering faculty have worked side by side for years. Now, the collaboration is official. The Keck School of Medicine of USC and USC Viterbi have launched the Alfred E. Mann Department of Biomedical Engineering, one of the first of its kind in CA. https://bme.usc.edu/
Flip through the Keck School of Medicine of USC's 2026 Dean's Report with us to learn more about how we leverage the full depth and breadth of USC's 23 schools to fuel innovation. Read the full report ➡️ https://keck.usc.edu/deans-report-2026/
Dean's POV 📸 This weekend, I hope you find time for something you love. As an avid cyclist, a recent 110+ mile ride reminded me how important it is to step away and recharge. Happy Memorial Day to our students, faculty, and staff. You've earned the break.
New USC study: 940 real-world patients, 5 ALK+ lung cancer drugs, and the first head-to-head comparison of lorlatinib and brigatinib outside of clinical trials. Alectinib showed the strongest survival signal at 46.5 months median. https://bit.ly/43gx4K7 #CancerResearch